The Effect of Doxycycline 100mg and Doxycycline 20mg in Treatment of Mild and Moderate Acne
This study is currently recruiting patients.
Verified by Shaheed Beheshti Medical University October 2006
| Sponsored by: |
Shaheed Beheshti Medical University |
| Information provided by: |
Shaheed Beheshti Medical University |
| ClinicalTrials.gov Identifier: |
NCT00388778 | |
Purpose
The purpose of this study is to compare the safety and efficacy of twice daily subantimicrobial dose doxycycline 20mg with daily doxycycline 100mg in treatment of mild and moderate Acne.
MedlinePlus related topics: Acne
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Dose Comparison, Parallel Assignment, Safety/Efficacy Study
Further study details as provided by Shaheed Beheshti Medical University:
Expected Total Enrollment: 100
Study start: October 2005; Expected completion: October 2006
Data entry closure: September 2006
Eligibility
Ages Eligible for Study: 18 Years - 40 Years, Genders Eligible for Study: Both
Accepts Healthy Volunteers
Criteria
Inclusion Criteria:
Exclusion Criteria:
Location and Contact Information
Please refer to this study by ClinicalTrials.gov identifier NCT00388778
Iran, Islamic Republic of
Skin Research Center, Shaheed Beheshti Medical University, Tehran, 19899, Iran, Islamic Republic of; Recruiting
Parviz Toossi, M.D. 98-21-22744392 src@sbmu.ac.ir
Parviz Toossi, M.D., Principal Investigator
Study chairs or principal investigators
Parviz Toossi, M.D., Principal Investigator, Shaheed Beheshti Medical University
More Information
Study ID Numbers: src-pts-964
Last Updated: October 16, 2006
Record first received: October 16, 2006
ClinicalTrials.gov Identifier: NCT00388778Health Authority: Iran: Ethics Committee
